Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06006455
Other study ID # R-TOT
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 15, 2020
Est. completion date March 1, 2025

Study information

Verified date May 2024
Source Erchonia Corporation
Contact Travis Sammons
Phone 8882420571
Email tsammons@erchonia.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this clinical study is to demonstrate the efficacy of the Erchonia LunulaLaser™, for the treatment of onychomycosis of the toenail.


Description:

This active test treatment group only study will evaluate the effectiveness of the Erchonia LunulaLaser™ manufactured by Erchonia Corporation (the Sponsor) for the treatment of onychomycosis of the toenail.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date March 1, 2025
Est. primary completion date February 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Confirmation of the presence of fungal infection through a positive KOH stain finding and a positive fungal culture finding - Identification through fungal culture of the growth of Trichophyton rubrum (T. rubrum) or other common dermatophyte - Visual clinical presentation of onychomycosis in the target great toenail is distal subungual onychomycosis (DSO), visualized as a nail with normal surface texture and thickness but variable "bays" of white nail that extend from the distal nail tip proximally into the area of the nail bed - Clinical involvement of onychomycosis in the target toenail is between 20%-50% - Subject is willing and able to refrain from employing other (non-study) treatments (traditional or alternative) for his or her toenail onychomycosis throughout study participation. - Subject is willing and able to refrain from the use of nail cosmetics such as clear and/or colored nail lacquers throughout study participation - Male or female - 18 years of age or older Exclusion Criteria: - Lack of confirmation of the presence of fungal infection through a negative KOH stain finding and/or a negative fungal culture finding - Visual clinical presentations of onychomycosis in the target great toenail that are inconsistent with the clinical presentation of distal subungual onychomycosis (DSO), in whole or in part (i.e. indicative of mixed etiology); specifically visual clinical presentations consistent with one or more of the following: - Proximal subungual onychomycosis (PSO): visualized as a white discoloration below the nail plate at the base of the nail, near the lunula. The distal nail retains normal appearance and texture. PSO involves infection near the matrix, deep to the nail. It may be associated with trauma to the nail or to immune compromise - Superficial white onychomycosis (SWO): visualized by the appearance of a white coating on the nail surface that can be eliminated by filing or buffing the surface of the affected portion of the nail - Complete dystrophy: Nails which are 100% dystrophic are manifested by yellowing and thickening of the entire nail unit - Other nail changes: Nails that visually present with changes that appear as parallel lines, small pinpoint depressions, brown spots, black or brown linear streaks, complete yellowing of all nails without textural change, green debris below the nail, or notches in the nail margin - Less than 2mm clear (unaffected) nail plate length beyond the proximal fold - Presence of dermatophytoma (thick masses of fungal hyphae and necrotic keratin between the nail plate and nail bed) - Infection involving lunula e.g., genetic nail disorders, primentary disorders - Severe plantar (moccasin) tinea pedis - Psoriasis of the skin and/or nails, lichen planus, or other medical conditions known to induce nail changes - Onychogryphosis - Trauma from ill-fitting shoes, running, or overly-aggressive nail care - Previous toenail surgery - Uncontrolled diabetes mellitus - Peripheral vascular disease - Recurrent cellulitis - Lymphatic insufficiency - Immune compromise (whether due to underlying medical disorders or immunosuppressive treatments) - Other compromised states of health - Known photosensitivity disorder - Use of oral antifungal drugs in the prior 6 months - Use of topical treatment of the skin or nails within the prior 2 months - Any abnormality of the toenail that could prevent a normal appearing nail from occurring if clearing of infection is achieved. - Current trauma, open wound on or about the treatment area - Deformity of the target toe/toenail secondary to fungal infection/onychomycosis due to prior injury, surgical procedures or another medical condition - Pregnant or planning pregnancy prior to the end of study participation - Serious mental health illness such as dementia or schizophrenia; psychiatric hospitalization in the past two years - Developmental disability or cognitive impairment that would preclude adequate comprehension of the informed consent form and/or ability to follow study subject requirements and/or record the necessary study measurements - Involvement in litigation and/or receiving disability benefits related in any way to the parameters of the study - Participation in a clinical study or other type of research in the past 30 days.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Erchonia LunulaLaser
405nm violet and 635nm red laser light therapy.

Locations

Country Name City State
United Kingdom Blemish Clinic Edenfield Cheshire

Sponsors (1)

Lead Sponsor Collaborator
Erchonia Corporation

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percent (%) of toenails attaining Complete Cure at study endpoint Complete Cure criteria is defined as a subject/toenail satisfying both the 'Clinical Cure' and the 'Mycological Cure' criteria in order to be considered a study responder, defined as follows:
(i) Clinical Cure: Measurement of clear nail increase as the following:
at least 12 mm increase in clear nail of the great toenail, with evidence of distal growth of the affected area, 12 months after the first treatment; or
complete clearance 12 months after the first treatment if less than 12 mm distal nail was involved prior to treatment.
The response should be progressive in at least 2 sequential timepoints that are at least 3 months apart, with projected increase of at least 1 mm per month.
(ii) Mycologic Cure: both negative KOH and negative Fungal Culture results (or two serial negative Fungal Culture results)
12 months
See also
  Status Clinical Trial Phase
Completed NCT03110029 - Evaluating the Efficacy and Compatibility of Efinaconazole 10% Solution (Jublia) for the Treatment of Toenail Onychomycosis in Patients Wearing Toenail Polish Compared to Those Without Polish Phase 4
Active, not recruiting NCT05110638 - Safety and Tolerability Study of SKX-16 in Subjects With Moderate to Severe Distal Subungual Onychomycosis Phase 1
Completed NCT05260450 - Laser Treatment of Toenail Onychomycosis With a 1064 nm Nd:YAG-laser N/A
Completed NCT03382717 - Efficacy and Safety of a Medical Device for the Treatment of Toenail Onychomycosis N/A
Not yet recruiting NCT06417983 - Topical Application of Essential Oils to Treat Onchomycosis
Withdrawn NCT03094468 - Study to Evaluate the Efficacy and Safety of P-3058 Nail Solution in the Treatment of Onychomycosis Phase 3
Recruiting NCT05674747 - Pilot Study of Swift Microwave Device for Onychomycosis Phase 1/Phase 2
Not yet recruiting NCT03098342 - Comparison of Efficacy and Safety Between Methylene Blue-mediated Photodynamic Therapy and 5% Amorolfine Nail Lacquer for Toenail Onychomycosis Treatment N/A
Completed NCT03216200 - Early Feasibility Study to Evaluate the Efficacy of the RenewalNail™ Plasma Treatment System in Patients With Onychomycosis (Fungal Nail) N/A
Recruiting NCT04042857 - Safety and Efficacy of Next Science Gel on Toenail Fungus N/A
Active, not recruiting NCT05135910 - To Evaluate Hallux Terbinafine Subungual Gel (HSG) in the Treatment of Onychomycosis Phase 2
Active, not recruiting NCT05139888 - Light Therapy for Onychomycosis Study N/A
Completed NCT04961684 - Clinical Evaluation of Efficacy and Safety of a Medical Device for the Treatment of Toenail Onychomycosis N/A
Completed NCT03141840 - Clinical Trial of Topical ABL01 Treatment of Onychomycosis N/A
Recruiting NCT04084782 - An Internet Mediated Research Study to Assess the Quality of Life of Consumers With Self-reported Fungal Nail Infection (Onychomycosis) During Treatment With Scholl Fungal Nail.
Withdrawn NCT03066336 - A Study to See if Low Level Laser Light Can Help to Treat Toenail Fungus N/A